Mankind Pharma Ltd AGM

2,081.2
(-1.29%)
Jul 23, 2024|03:32:40 PM

Mankind Pharma CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeAGM DateAnnouncement Date
AGM22 Sep 202324 Aug 2023
Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with various circulars issued by the Ministry of Corporate Affairs, we hereby enclose copies of newspaper advertisement published in Financial Express and Jansatta on August 24, 2023 regarding ensuing Annual General Meeting of the Company to be held on Friday, September 22, 2023 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) and information relating to e-voting. Notice of 32nd Annual General Meeting along with copy of the Annual Report for F.Y. 2022-23 (As Per BSE Announcement Dated on 28/08/2023) Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and in compliance with various circulars issued by the Ministry of Corporate Affairs, we hereby enclose copies of newspaper advertisement published in Financial Express and Jansatta on August 29, 2023 regarding 32nd Annual General Meeting of the Company to be held on Friday, September 22, 2023 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) and information relating to e-voting. (As Per BSE Announcement Dated on 29/08/2023) Voting Results and Consolidated Scrutinisers Report of the 32nd Annual General Meeting of Mankind Pharma Limited (As Per BSE Announcement dated on 25.09.2023)

Mankind Pharma: Related News

Mankind Pharma inks pact with Takeda to market Vonoprazan
18 Jul 2024|10:48 AM

The Delhi-based startup has signed in-licensing arrangements with Novartis for the heart failure treatment Neptaz.

Read More
₹771 Crore Block Deal Shakes Up Mankind Pharma Stock
10 Jul 2024|10:14 AM

Mankind Pharma's stock increased by more than 4% after the block deal. Mankind Pharma's shares were trading at ₹2,169 on the NSE at 09.23 am.

Read More
Top 10 stocks for today – 10th July 2024
10 Jul 2024|10:26 AM

Here are some of the stocks that may see significant price movement today: ONGC, Wipro, Reliance, RVNL, Mahindra & Mahindra, etc.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.